Scaling is difficult for any company. But when your business is primed for Covid-19, growth can be as viral as the disease. That’s the case for Cue Health, a San Diego-based health care technology ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc ...

The U.S. Food and Drug Administration told consumers Monday to throw out any at-home COVID-19 tests made by San Diego biotech Cue Health, because they could give users false results. Early in the ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits.

Cue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the NBA and Google, is laying off all employees and shutting down on Friday. Cue’s closure comes a week after ...

Cue Health’s device to test for covid-19 costs $249 plus $195 for a pack of three tests, which puts it out of reach for many consumers. Cue’s share price has plummeted since the company went public in ...

A contributed photo from Cue Health shows how the test can be administered and read via a cartridge reader connected to a mobile device. Public school districts across the country are on the lookout ...

Though many companies expect the demand for COVID-19 testing to wane in the coming months, investors are hoping the public remains hungry for the progress made in having healthcare work nearly ...

Cue Health Inc (NASDAQ:HLTH) became the first company to receive De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use. The de novo is a ...

HHS’ Biomedical Advanced Research and Development Authority will provide additional funds to its ongoing partnership with San Diego-based Cue Health, a healthcare technology company, to develop an ...

June 6 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Cue Health's (HLTH.O), opens new tab at-home COVID-19 test, the first coronavirus test to get marketing authorization using ...

Test maker and health tech company Cue Health Inc. is seeking to sell more than 12 million shares in a range between $12 and $17 each, looking to raise more than $244 million, according to an amended ...